Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research

Cites (308)

Items 201–308 of 308

1. Perfluoroalkyl substances and risk of type II diabetes: A prospective nested case-control study
   Donat-Vargas, Carolina, Bergdahl, Ingvar A., Tornevi, Andreas, Wennberg, Maria, Sommar, Johan, Kiviranta, Hannu, Koponen, Jani, Rolandsson, Olov, Åkesson, Agneta · 2019 · Environment International
2. Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study
   Panu Rantakokko, Ville Männistö, Riikka Airaksinen · 2015 · Environmental Health
3. Roles of gender and obesity in defining correlations between perfluoroalkyl substances and lipid/lipoproteins
   Ram Baboo Jain, ALAN M. DUCATMAN · 2018 · The Science of The Total Environment
4. Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes
   Thorsten Buhrke, Eileen Krüger, Sophie Pevny, Manuela Rößler, Katja Bitter, Alfonso Lampen · 2015 · Toxicology
5. Developmental toxicity of perfluorononanoic acid in mice
   Kaberi P. Das, Brian E. Grey, Mitchell B. Rosen, Carmen R. Wood, Katoria R. Tatum-Gibbs, R. Daniel Zehr, Mark J. Strynar, Andrew B. Lindstrom, Christopher S. Lau · 2014 · Reproductive Toxicology
6. Identification of metabolic profiles associated with human exposure to perfluoroalkyl substances
   Samira Salihović, Tove Fall, Andrea Ganna, Corey D. Broeckling, Jessica E. Prenni, Tuulia Hyötyläinen, Anna Kärrman, Peter Lind, Erik Ingelsson, Lars Lind · 2018 · Journal of Exposure Science & Environmental Epidemiology
7. Acute PFOA exposure promotes epigenomic alterations in mouse kidney tissues
   Faizan Rashid, Anujaianthi Ramakrishnan, Christopher J. Fields, Joseph Irudayaraj · 2020 · Toxicology Reports
8. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study
   Michael Marc Borghese, MARK C. WALKER, Michael E. Helewa, William Donald Fraser, Tye Elaine Arbuckle · 2020 · Environment International
9. Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding
   Megan E. Romano, Yingying Y. Xu, Antonia M. Calafat, Kimberly A. Yolton, Aimin Chen, Glenys M. Webster, Melissa Eliot, Cynthia Ruth Howard, Bruce Perrin Lanphear, Joseph M. Braun · 2016 · Environmental Research
10. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
    Omar I. Massoud, Michael Charlton · 2017 · Clinics in Liver Disease
11. Per- and Polyfluoroalkyl Substances Differentially Inhibit Placental Trophoblast Migration and Invasion In Vitro
    John T. Szilagyi, Anastasia N. Freedman, Stewart L Kepper, Arjun M Keshava, Jackie T Bangma, Rebecca C. Fry · 2020 · Toxicological Sciences
12. Solvent Suitability for HFPO-DA (“GenX” Parent Acid) in Toxicological Studies
    Hannah K. Liberatore, Stephen R. Jackson, Mark J. Strynar, James P. McCord · 2020 · Environmental Science & Technology Letters
13. A Permeability-Limited Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctanoic acid (PFOA) in Male Rats
    Weixiao Cheng, Carla A. Ng · 2017 · Environmental Science & Technology
14. Genomic Profiling Reveals an Alternate Mechanism for Hepatic Tumor Promotion by Perfluorooctanoic Acid in Rainbow Trout
    Susan C. Tilton, Gayle A. Orner, Abby D. Benninghoff, Hillary M. Carpenter, Jerry D. Hendricks, Cliff B. Pereira, David E. Williams · 2008 · Environmental Health Perspectives
15. Understanding Environmental Contaminants’ Direct Effects on Non-alcoholic Fatty Liver Disease Progression
    Laura E. Armstrong, Grace Liejun Guo · 2019 · Current Environmental Health Reports
16. Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women
    S. Wikström, Christian H. Lindh, H. Shu, Carl-Gustaf Bornehag · 2019 · Scientific Reports
17. Analysis of PFOA in dosed CD-1 mice. Part 2: Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups
    S. Fenton, Jessica L. Reiner, S. Nakayama, Amy D. Delinsky, J. Stanko, E. Hines, S. White, A. Lindstrom, M. Strynar, Syrago-Styliani E. Petropoulou · 2009 · Reproductive Toxicology
18. Positive Association Between Perfluoroalkyl Chemicals and Hyperuricemia in Children
    Sarah Dee Geiger, Jie Xiao, A. Shankar · 2013 · American Journal of Epidemiology
19. Adiposity and Glycemic Control in Children Exposed to Perfluorinated Compounds
    Clara Amalie Gade Timmermann, Laura I. Rossing, Anders Grøntved, Mathias Ried‐Larsen, Christine Dalgård, Lars Bo Andersen, Philippe Grandjean, Flemming Nielsen, Kira Dynnes Svendsen, Thomas Scheike et al. · 2014 · The Journal of Clinical Endocrinology & Metabolism
20. Advancing the adverse outcome pathway framework—An international horizon scanning approach
    Carlie A. LaLone, Gerald T. Ankley, Scott E. Belanger et al. · 2017 · Environmental Toxicology and Chemistry
21. Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States)
    Rachel Cluett, Shravanthi M. Seshasayee, Lisa B. Rokoff, Sheryl L. Rifas‐Shiman, Xiaoyun Ye, Antonia M. Calafat, Diane R. Gold, Brent A. Coull, Catherine M. Gordon, Clifford james Rosen et al. · 2019 · Environmental Health Perspectives
22. Perfluorinated alkyl substances in serum of the southern Chinese general population and potential impact on thyroid hormones
    Yangjie Li, Yating Cheng, Zhiyong Xie, Feng Zeng · 2017 · Scientific Reports
23. PFOA and ulcerative colitis
    Kyle Steenland, Subra Kugathasan, Dana Boyd Barr · 2018 · Environmental Research
24. High exposure to perfluorinated compounds in drinking water and thyroid disease. A cohort study from Ronneby, Sweden
    Eva M. Andersson, Kristin Scott, Yiyi Xu, Ying Li, Daniel S Olsson, Tony Fletcher, Kristina Jakobsson · 2019 · Environmental Research
25. Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort
    Jordan Stubleski, Samira Salihović, Lars Lind, Peter Lind, Bert van Bavel, Anna Kärrman · 2016 · Environment International
26. Perfluoroalkyl Acids (PFAAs) in Serum from 2–4-Month-Old Infants: Influence of Maternal Serum Concentration, Gestational Age, Breast-Feeding, and Contaminated Drinking Water
    Irina Gyllenhammar, Jonathan P. Benskin, Oskar Sandblom, Urs Berger, Lutz Ahrens, Sanna Lignell, Karin Wiberg, Anders Wicklund Glynn · 2018 · Environmental Science & Technology
27. Selective Associations of Recent Low Concentrations of Perfluoroalkyl Substances With Liver Function Biomarkers
    Ram Baboo Jain, ALAN M. DUCATMAN · 2018 · Journal of Occupational and Environmental Medicine
28. Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water
    Yiyi Xu, Ying Li, Kristin Scott, Christian H. Lindh, Kristina Jakobsson, Tony Fletcher, Bodil Ohlsson, Eva M. Andersson · 2019 · Environmental Research
29. Structure-Based Virtual Screening Protocol for in Silico Identification of Potential Thyroid Disrupting Chemicals Targeting Transthyretin
    Jin Zhang, Afshan Begum, Kristoffer Brännström, Christin Grundström, Irina Iakovleva, Anders Olofsson, A.E. Sauer-Eriksson, Patrik L. Andersson · 2016 · Environmental Science & Technology
30. Perfluoroalkyl substances and endometriosis in US women in NHANES 2003–2006
    Stephanie Campbell, Masooma Raza, Anna Z. Pollack · 2016 · Reproductive Toxicology
31. Perfluoroalkyl substances follow inverted U-shaped distributions across various stages of glomerular function: Implications for future research
    Ram Baboo Jain, ALAN M. DUCATMAN · 2018 · Environmental Research
32. Sex differences in the association between perfluoroalkyl acids and liver function in US adolescents: Analyses of NHANES 2013–2016
    Attanasio, Roberta · 2019 · Environmental Pollution
33. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China
    Xiao‐Wen Zeng, Caroline Lodge, Shyamali C. Dharmage, Michael S. Bloom, Yunjiang Yu, Mo Yang, Chu Chu, Qingqing Li, Li‐Wen Hu, Kangkang Liu et al. · 2019 · Environment International
34. Consumption of Seafood, Serum Liver Enzymes, and Blood Levels of PFOS and PFOA in the Japanese Population
    Miwa Yamaguchi, Kokichi Arisawa, Hirokazu Uemura, Sakurako Katsuura‐Kamano, Hidenobu Takami, Fusakazu Sawachika, Mariko Nakamoto, Tomoya Juta, Eisaku Toda, Kei Mori et al. · 2013 · Journal of Occupational Health
35. Perfluorochemicals and Endometriosis
    Germaine M. Buck Louis, C. Matthew Peterson, Zhen Chen, Mary L. Hediger, Mary S. Croughan, Rajeshwari Sundaram, Joseph B. Stanford, Victor Y. Fujimoto, Michael Walter Varner, Linda C. Giudice et al. · 2012 · Epidemiology
36. Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid
    Conny Karnes, Andrea G. Winquist, Kyle Steenland · 2013 · Environmental Research
37. Perfluoroalkyl Substances Stimulate Insulin Secretion by Islet β Cells via G Protein-Coupled Receptor 40
    Qin, Wei-Ping, Cao, Lin-Ying, Li, Chuan-Hai, Guo, Liang-Hong, Colbourne, John, Ren, Xiao-Min · 2020 · Environmental Science & Technology
38. Evaluating the additivity of perfluoroalkyl acids in binary combinations on peroxisome proliferator-activated receptor-α activation
    Wolf, Cynthia J., Rider, Cynthia V., Lau, Christopher, Abbott, Barbara D. · 2014 · Toxicology
39. Hypercholesterolemia with Consumption of PFOA-Laced Western Diets Is Dependent on Strain and Sex of Mice
    Rebholz, Sandra L., Jones, Thomas, Herrick, Robert L., Xie, Changchun, Calafat, Antonia M., Pinney, Susan M., Woollett, Laura A. · 2016 · Toxicology Reports
40. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study
    Gang Liu, Bo Zhang, Yang Hu, Jennifer Rood, Liming Liang, Lu Qi, George A. Bray, Lilian de Jonge, Brent A. Coull, Philippe Grandjean et al. · 2020 · Environmental Health
41. In vitro and in silico modeling of perfluoroalkyl substances mixture toxicity in an amphibian fibroblast cell line
    Hoover, Gary, Kar, Supratik, Guffey, Samuel, Leszczynski, Jerzy, Sepúlveda, Maria S. · 2019 · Chemosphere
42. Probabilistic human health risk assessment of perfluorooctane sulfonate (PFOS) by integrating in vitro, in vivo toxicity, and human epidemiological studies using a Bayesian-based dose-response assessment coupled with physiologically based pharmacokinetic (PBPK) modeling approach
    Wei‐Chun Chou, Zhoumeng Lin · 2020 · Environment International
43. Hepatic Mitochondrial Alteration in CD-1 Mice Associated with Prenatal Exposures to Low Doses of Perfluorooctanoic Acid (PFOA)
    Erin M. Quist, Adam J. Filgo, Connie A. Cummings, Grace E. Kissling, Mark James Hoenerhoff, Suzanne E. Fenton · 2014 · Toxicologic Pathology
44. PFOA evokes extracellular Ca2+ influx and compromises progesterone-induced response in human sperm
    Yangyang Yuan, Xinbao Ding, Yimin Cheng, Hang Won Kang, Tao Luo, Xiaoning Zhang, Haibin Kuang, Ying Chen, Xuhui Zeng, Dalei Zhang · 2019 · Chemosphere
45. Longitudinal trends of per- and polyfluoroalkyl substances in children's serum
    Jani M. Koponen, Kerstin Winkens, Riikka Airaksinen, Urs Berger, Robin Vestergren, Ian T. Cousins, Anne M. Karvonen, Juha Pekkanen, Hannu Kiviranta · 2018 · Environment International
46. Associations of Fetal Growth Outcomes with Measures of the Combined Xenoestrogenic Activity of Maternal Serum Perfluorinated Alkyl Acids in Danish Pregnant Women
    Christian Bjerregaard‐Olesen, Cathrine Carlsen Bach, Manhai Long, Maria Wielsøe, Bodil Hammer Bech, Tine Brink Henriksen, Jørn Olsen, Eva Cecilie Bonefeld‐Jørgensen · 2019 · Environmental Health Perspectives
47. Rat Organic Anion Transporter 3 and Organic Anion Transporting Polypeptide 1 Mediate Perfluorooctanoic Acid Transport
    Masanori Katakura, Naomi Kudo, Tadashi Tsuda, Yasuhide Hibino, Atsushi Mitsumoto, Yoichi Kawashima · 2007 · Eisei kagaku
48. Serum perfluoroalkyl substances and cardiometabolic consequences in adolescents exposed to the World Trade Center disaster and a matched comparison group
    Tony T. Koshy, Teresa M. Attinà, Akhgar Ghassabian, Joseph Gilbert, Lauren K. Burdine, Michael F. Marmor, Masato Honda, Dinh Binh Chu, Xiaoxia Han, Yongzhao Shao et al. · 2017 · Environment International
49. Associations of exposure to perfluoroalkyl substances with thyroid hormone concentrations and birth size.
    C. Xiao, P. Grandjean, D. Valvi, F. Nielsen, T. K. Jensen, P. Weihe, Y. Oulhote · 2019 · Journal of Clinical Endocrinology and Metabolism
50. Negative Association Between Serum Perfluorooctane Sulfate Concentration and Bone Mineral Density in US Premenopausal Women: NHANES, 2005–2008
    Lian‐Yu Lin, Li‐Li Wen, Ta‐Chen Su, Pau‐Chung Chen, Chien‐Yu Lin · 2014 · The Journal of Clinical Endocrinology & Metabolism
51. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure
    Vaughn Barry, Lyndsey A. Darrow, Mitchel Klein, Andrea G. Winquist, Kyle Steenland · 2014 · Environmental Research
52. The derivation of a Reference Dose (RfD) for perfluorooctane sulfonate (PFOS) based on immune suppression
    Brian F. Pachkowski, Gloria B. Post, Alan H. Stern · 2018 · Environmental Research
53. Associations between serum concentrations of perfluoroalkyl acids and serum lipid levels in a Chinese population
    Yaning Fu, Tieyu Wang, Quanliang Fu, Pei Wang, Yonglong Lü · 2014 · Ecotoxicology and Environmental Safety
54. Perfluorooctanesulfonate Mediates Renal Tubular Cell Apoptosis through PPARgamma Inactivation
    Li-Li Wen, Chien‐Yu Lin, Hsiu‐Chu Chou, Chih‐Cheng Chang, Hau-Yin Lo, Shu‐Hui Juan · 2016 · PLoS ONE
55. Probing the Cell Apoptosis Pathway Induced by Perfluorooctanoic Acid and Perfluorooctane Sulfonate at the Subcellular and Molecular Levels
    Mengchen Xu, Guiliang Liu, Meifei Li · 2019 · Journal of Agricultural and Food Chemistry
56. Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances
    Clara Amalie Gade Timmermann, Esben Budtz–Jørgensen, Maria Skaalum Petersen, Pál Weihe, Ulrike Steuerwald, Flemming Nielsen, Tina Kold Jensen, Philippe Grandjean · 2016 · Reproductive Toxicology
57. Perfluoroalkyl Substances and Maternal Thyroid Hormones in Early Pregnancy; Findings in the Danish National Birth Cohort
    Kosuke Inoue, Beate R. Ritz, Stine Linding Andersen, Cecilia Høst Ramlau‐Hansen, Birgit Bjerre Høyer, Bodil Hammer Bech, Tine Brink Henriksen, Eva Cecilie Bonefeld‐Jørgensen, Jørn Olsen, Zeyan Liew · 2019 · Environmental Health Perspectives
58. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination
    Clara Amalie Gade Timmermann, Esben Budtz–Jørgensen, Tina Kold Jensen, Christa Elyse Osuna, Maria Skaalum Petersen, Ulrike Steuerwald, Flemming Nielsen, Lars Kaergaard Poulsen, Pál Weihe, Philippe Grandjean · 2017 · Journal of Immunotoxicology
59. Binding specificities of estrogen receptor with perfluorinated compounds: A cross species comparison
    Zhiqiang Qiu, Kaili Qu, Feng Luan · 2019 · Environment International
60. Positive associations of serum perfluoroalkyl substances with uric acid and hyperuricemia in children from Taiwan
    Xiao-Di Qin, Zhengmin Min Qian, Michael G. Vaughn, Jin Huang, Patrick Ward, Xiao‐Wen Zeng, Yang Zhou, Yu Zhu, Ping Yuan, Meng Li et al. · 2016 · Environmental Pollution
61. Impact of Perfluorooctane Sulfonate on Reproductive Ability of Female Mice through Suppression of Estrogen Receptor α-Activated Kisspeptin Neurons
    Xiaoli Wang, Yingyang Bai, Chuanfeng Tang, Xinyuan Cao, Fei Chang, Ling Chen · 2018 · Toxicological Sciences
62. Perturbation of Nuclear Hormone Receptors by Endocrine Disrupting Chemicals: Mechanisms and Pathological Consequences of Exposure
    J. M. Hall, Callie W. Greco · 2019 · Cells
63. Computational Molecular Modeling for Evaluating the Toxicity of Environmental Chemicals: Prioritizing Bioassay Requirements
    James R. Rabinowitz, Michael‐Rock Goldsmith, Stephen B. Little, Melissa A. Pasquinelli · 2008 · Environmental Health Perspectives
64. Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)
    Matteo Convertino, Timothy R. Church, Geary W. Olsen, Yang Liu, Eddie Doyle, Clifford R. Elcombe, Anna L Barnett, Leslie M. Samuel, Iain R. Macpherson, T.R.J. Evans · 2018 · Toxicological Sciences
65. Perfluoroalkyl substances in serum from South Korean infants with congenital hypothyroidism and healthy infants – Its relationship with thyroid hormones
    Da‐Hye Kim, Un‐Jung Kim, Hee-Young Kim, Sung‐Deuk Choi, Jeong‐Eun Oh · 2016 · Environmental Research
66. Lipid accumulation responses in the liver of Rana nigromaculata induced by perfluorooctanoic acid (PFOA)
    Hangjun Zhang, Jianbo He, Ning Li, Nana Gao, Qiongxia Du, Bin Chen, Feifei Chen, Xiaodong Shan, Ying Ding, Weiqin Zhu et al. · 2018 · Ecotoxicology and Environmental Safety
67. Investigation of binding and activity of perfluoroalkyl substances to the human peroxisome proliferator-activated receptor β/δ
    Chuan-Hai Li, Xiaomin Ren, Lin-Ying Cao, Weiping Qin, Liang‐Hong Guo · 2019 · Environmental Science Processes & Impacts
68. Exposure to perfluoroundecanoic acid (PFUnDA) accelerates insulitis development in a mouse model of type 1 diabetes
    Bodin, Johanna, Groeng, Else-Carin, Andreassen, Monica, Dirven, Hubert, Nygaard, Unni Cecilie · 2016 · Toxicology Reports
69. Interactions between three typical endocrine-disrupting chemicals (EDCs) in binary mixtures exposure on myocardial differentiation of mouse embryonic stem cell
    Ren Zhou, Wei Cheng, Yan Feng, Hongying Wei, Fan Liang, Yan Wang · 2017 · Chemosphere
70. Perfluoroalkyl Chemicals, Menstrual Cycle Length, and Fecundity: Findings from a Prospective Pregnancy Study
    Kirsten J. Lum, R. Sundaram, D. Barr, T. Louis, G. B. Buck Louis · 2017 · Epidemiology
71. Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight Gain
    J. Ashley-Martin, L. Dodds, T. Arbuckle, A. Morisset, M. Fisher, M. Bouchard, Gabriel D. Shapiro, A. Ettinger, P. Monnier, R. Dallaire et al. · 2016 · International Journal of Environmental Research and Public Health
72. Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study
    Xiaona Huo, Rong Huang, Yuexin Gan, Kai Luo, Ruxianguli Aimuzi, Min Nian, Junjie Ao, Liping Feng, Ying Tian, Weiye Wang et al. · 2020 · Environment International
73. Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study
    Yang Hu, Gang Liu, Jennifer Rood, Liming Liang, George A. Bray, Lilian de Jonge, Brent A. Coull, Jeremy D. Furtado, Lu Qi, Philippe Grandjean et al. · 2019 · Environmental Research
74. Persistent endocrine-disrupting chemicals found in human follicular fluid stimulate the proliferation of granulosa tumor spheroids via GPR30 and IGF1R but not via the classic estrogen receptors
    Justyna Gogola-Mruk, Marta Hoffmann, Anna Ptak · 2018 · Chemosphere
75. Estimating Environmental Hazard and Risks from Exposure to Per- and Polyfluoroalkyl Substances (PFASs): Outcome of a SETAC Focused Topic Meeting
    Mark S. Johnson, Robert C. Buck, Ian T. Cousins, Christopher Weis, Suzanne E. Fenton · 2020 · Environmental Toxicology and Chemistry
76. Examining confounding by diet in the association between perfluoroalkyl acids and serum cholesterol in pregnancy
    Margret Skuladottir, Alfons Ramel, Dorte Rytter, Line Småstuen Haug, Azemira Sabaredzovic, Bodil Hammer Bech, Tine Brink Henriksen, Sjurdur Frodi Olsen, Thorhallur Ingi Halldorsson · 2015 · Environmental Research
77. Exploring open cheminformatics approaches for categorizing per- and polyfluoroalkyl substances (PFASs)
    Bo Sha, Emma Schymanski, Christoph Ruttkies, Ian T. Cousins, Zhanyun Wang · 2019 · Environmental Science Processes & Impacts
78. Perfluorooctane sulfonate acute exposure stimulates insulin secretion via GPR40 pathway
    Lianying Zhang, Xiaoyu Duan, Weijie Sun, Hongwen Sun · 2020 · The Science of The Total Environment
79. Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver
    Thomas Jensen, Koichiro Niwa, Ichiro Hisatome, Mehmet Kanbay, Ana Andrés-Hernando, Carlos A. Roncal-Jiménez, Yuka Sato, Gabriela García, Minoru Ohno, Miguel Angel Lanaspa et al. · 2018 · Scientific Reports
80. The impact of exposure to environmental contaminant on hepatocellular lipid metabolism
    Zongguang Hui, Rujiang Li, Li Chen · 2017 · Gene
81. Reducing exposure to high levels of perfluorinated compounds in drinking water improves reproductive outcomes: evidence from an intervention in Minnesota
    Gina Waterfield, M. Rogers, P. Grandjean, M. Auffhammer, D. Sunding · 2020 · Environmental Health
82. In utero exposure to perfluorooctanoate (PFOA) or perfluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice
    Ha Thi Ngo, Ragna Bogen Hetland, Azemira Sabaredzovic, Line Småstuen Haug, Inger‐Lise Steffensen · 2014 · Environmental Research
83. Gestational Exposure to Perfluorooctanoic Acid (PFOA): Alterations in Motor Related Behaviors
    Goulding, David R., White, Sally S., McBride, Sandra J., Fenton, Suzanne E., Harry, G. Jean · 2017 · NeuroToxicology
84. Metabolically inert perfluorinated fatty acids directly activate uncoupling protein 1 in brown-fat mitochondria
    Irina G. Shabalina, Anastasia Kalinovich, Barbara Cannon, Jan Nedergaard · 2015 · Archives of Toxicology
85. Perfluoroalkyl substances and bone health in young men: a pilot study
    Andrea Di Nisio, Maurizio De Rocco Ponce, A. Giadone, Maria Santa Rocca, Diego Guidolin, Carlo Foresta · 2019 · Endocrine
86. Perfluoroalkyl acids and time to pregnancy revisited: An update from the Danish National Birth Cohort
    Cathrine Carlsen Bach, Zeyan Liew, Bodil Hammer Bech, Ellen Aagaard Nohr, Chunyuan Fei, Eva Cecilie Bonefeld‐Jørgensen, Tine Brink Henriksen, Jørn Olsen · 2015 · Environmental Health
87. Dynamics of associations between perfluoroalkyl substances and uric acid across the various stages of glomerular function
    Ram Baboo Jain, ALAN M. DUCATMAN · 2019 · Environmental Science and Pollution Research
88. Programming of metabolic effects in C57BL/6JxFVB mice by in utero and lactational exposure to perfluorooctanoic acid
    Joantine C.J. van Esterik, Liana Bastos Sales, Martijn E.T. Dollé, Helen Håkansson, Maria Herlin, Juliette Legler, Leo T.M. van der Ven · 2015 · Archives of Toxicology
89. Editor’s Highlight: Perfluorooctane Sulfonate-Choline Ion Pair Formation: A Potential Mechanism Modulating Hepatic Steatosis and Oxidative Stress in Mice
    Limin Zhang, Prasad Krishnan, David J. Ehresman · 2016 · Toxicological Sciences
90. Testing for departures from additivity in mixtures of perfluoroalkyl acids (PFAAs)
    Caroline K. Carrico, Andrew M. Watkins, Cynthia J. Wolf, Barbara D. Abbott, Christopher S. Lau, Chris Gennings · 2013 · Toxicology
91. Perfluorooctane Sulfonate Induces Autophagy-Dependent Apoptosis through Spinster 1-Mediated lysosomal-Mitochondrial Axis and Impaired Mitophagy
    Xiaofeng Yao, Shanshan Sha, Yuexia Wang, Xiance Sun, Jun Cao, Jian Kang, Liping Jiang, Min Chen, Yufang Ma · 2016 · Toxicological Sciences
92. Persistent pollutants: focus on perfluorinated compounds and kidney
    Fiorenza Ferrari, Anita Orlando, Zaccaria Ricci, Claudio Ronco · 2019 · Current Opinion in Critical Care
93. Molecular Mechanisms of Perfluorooctanoate-Induced Hepatocyte Apoptosis in Mice Using Proteomic Techniques
    Kan Li, Jie Sun, Jingping Yang, Stephen M. Roberts, Xuxiang Zhang, Xinyi Cui, Si Wei, Lena Qiying Ma · 2017 · Environmental Science & Technology
94. Exposure of female mice to perfluorooctanoic acid suppresses hypothalamic kisspeptin‐reproductive endocrine system through enhanced hepatic fibroblast growth factor 21 synthesis, leading to ovulation failure and prolonged dioestrus
    Yajie Zhang, Xinyuan Cao, Lin Chen, Yaoyao Qin, Ye Xu, Ying Tian, Ling Chen · 2020 · Journal of Neuroendocrinology
95. Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice
    Marianne G. Pouwer, Elsbet Jantine Pieterman, Shu‐Ching Chang, Geary W. Olsen, Martien P. M. Caspers, Lars Verschuren, J. Wouter Jukema, Hans M. G. Princen · 2019 · Toxicological Sciences
96. Causal inference for the effect of environmental chemicals on chronic kidney disease
    Jing Zhao, Paige Hinton, Junyi Chen, Jing Jiang · 2019 · Computational and Structural Biotechnology Journal
97. Antagonistic Estrogenic Effects Displayed by Bisphenol AF and Perfluorooctanoic Acid on Zebrafish (Danio rerio) at an Early Developmental Stage
    Pengyu Chen, Qiang Wang, Meng Chen, Jing Chun Yang, Ruihan Wang, Wenjue Zhong, Lingyan Y. Zhu, Lihua Yang · 2018 · Environmental Science & Technology Letters
98. Breastfeeding as a Predictor of Serum Concentrations of Per- and Polyfluorinated Alkyl Substances in Reproductive-Aged Women and Young Children: A Rapid Systematic Review
    Brianna N. VanNoy, Juleen Lam, A. Zota · 2018 · Current Environmental Health Reports
99. Intrauterine exposure to perfluorinated compounds and overweight at age 4: A case-control study
    Matilda Martinsson, Christel Nielsen, Jonas Björk, Lars Rylander, Ebba Malmqvist, Christian H. Lindh, Anna Rignell‐Hydbom · 2020 · PLoS ONE
100. Maternal Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Breastfeeding Duration in the Norwegian Mother and Child Cohort
     Emma M. Rosen, Anne Lise Brantsæter, Rachel M. Carroll, Line Småstuen Haug, Alison B. Singer, Shanshan Zhao, Kelly K. Ferguson · 2018 · Environmental Epidemiology
101. Within- and between-group regression for improving the robustness of causal claims in cross-sectional analysis
     Genser, Bernd, Teles, Carlos A., Barreto, Mauricio L., Fischer, Joachim E. · 2015 · Environmental Health
102. Impact of Exposure Uncertainty on the Association between Perfluorooctanoate and Preeclampsia in the C8 Health Project Population
     Raghavendhran Avanasi, Hyeong‐Moo Shin, Verónica M. Vieira, David A. Savitz, Scott M. Bartell · 2015 · Environmental Health Perspectives
103. A Two-Stage Model for Lipid Modulation of the Activity of Integral Membrane Proteins
     Martín M. Dodes Traian, Diego Ignacio Cattoni, Valeria Levi · 2012 · PLoS ONE
104. Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project Population
     Raghavendhran Avanasi, Hyeong-Moo Shin, V. Vieira, S. Bartell · 2016 · Environmental Research
105. Changes in hepato-renal gene expression in microminipigs following a single exposure to a mixture of perfluoroalkyl acids
     Akiko Sakuma, Haruyo Wasada Ochi, Miyako Yoshioka, Noriko Yamanaka, Mitsutaka Ikezawa, Keerthi S. Guruge · 2019 · PLoS ONE
106. Variabilities in concentrations of selected perfluoroalkyl acids among normotensives and hypertensives across various stages of glomerular function
     Ram Baboo Jain · 2020 · Archives of Environmental & Occupational Health
107. Cardiovascular Implications of Diabetes, Metabolic Syndrome, Thyroid Disease, and Cardio-Oncology in Women
     Marijana Vaso Tadic, Cesare Cuspidi, Dragan Vasić, Peter L. M. Kerkhof · 2018 · Advances in experimental medicine and biology
108. A hypothesis-driven weight-of-evidence analysis to evaluate potential endocrine activity of perfluorohexanoic acid
     Susan J. Borghoff, Seneca Fitch, Julia E. Rager, Duane B. Huggett · 2018 · Regulatory Toxicology and Pharmacology